Concourse Financial Group Securities’s Strategic Trust Kelly CRISPR & Gene Editing Technology ETF XDNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Hold |
0
| – | – | – | 10363 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 10111 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 9888 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 9522 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 9529 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 9334 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 9158 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 8944 |
|